Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in recurrent miscarriage
NCT03902912Phase 3Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jul 2019
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of prednisolone in recurrent miscarriage (RPL), sponsored by The Chinese University of Hong Kong. Primary endpoint: number of uterine natural killer cells. Started Jul 2019; status: recruiting.
02
Drugs
prednisolone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT03902912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03902912.